Skip to main content

Rabbit Recombinant Monoclonal ACL6A antibody. Suitable for ICC/IF, WB and reacts with Human samples. Immunogen corresponding to Synthetic Peptide within Human ACTL6A.

Be the first to review this product! Submit a review

Images

Western blot - Anti-BAF53A Antibody [RP23040194] (AB313478), expandable thumbnail
  • Immunocytochemistry/ Immunofluorescence - Anti-BAF53A Antibody [RP23040194] (AB313478), expandable thumbnail

Key facts

Isotype
IgG
Host species
Rabbit
Storage buffer
Standard buffer
Clonality
Monoclonal

Immunogen

  • Synthetic Peptide within Human ACTL6A. Database link O96019

Reactivity data

Select an application
Product promiseTestedExpectedPredictedNot recommended
ICC/IFWB
Human
Tested
Tested

Tested
Tested

Species
Human
Dilution info
2 µg/mL
Notes

-

Tested
Tested

Species
Human
Dilution info
1.00000-2.00000 µg/mL
Notes

-

Target data

Function

Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. Required for maximal ATPase activity of SMARCA4/BRG1/BAF190A and for association of the SMARCA4/BRG1/BAF190A containing remodeling complex BAF with chromatin/nuclear matrix. Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and is required for the proliferation of neural progenitors. During neural development a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth (By similarity). Component of the NuA4 histone acetyltransferase (HAT) complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A. This modification may both alter nucleosome - DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. This complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and DNA repair. NuA4 may also play a direct role in DNA repair when recruited to sites of DNA damage. Putative core component of the chromatin remodeling INO80 complex which is involved in transcriptional regulation, DNA replication and probably DNA repair.

Alternative names

Recommended products

Rabbit Recombinant Monoclonal ACL6A antibody. Suitable for ICC/IF, WB and reacts with Human samples. Immunogen corresponding to Synthetic Peptide within Human ACTL6A.

Key facts

Isotype
IgG
Clonality
Monoclonal
Immunogen
  • Synthetic Peptide within Human ACTL6A. Database link O96019
Clone number
RP23040194
Concentration
Loading...

Notes

Recombinant multiclonals are a mixture of recombinant antibodies co-expressed from a library of heavy and light chains.

Recombinant multiclonal antibodies offer the sensitivity of polyclonal antibodies by recognising multiple epitopes, along with consistency of a recombinant antibody.

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

The protein BAF53A also known as ACTL6A plays an important role in gene expression through chromatin remodeling. It is a subunit of the SWI/SNF-like BAF complex that is responsible for altering chromatin structure making it easier for transcription factors to access DNA. BAF53A has a molecular mass of approximately 53 kDa. It is highly expressed in neurons and plays an essential role in neurodevelopment and the regulation of neuronal gene expression.

Biological function summary

BAF53A is an integral component of the BAF chromatin remodeling complex. This complex modifies the positioning and accessibility of nucleosomes on chromatin thereby influencing gene transcription processes. BAF53A contributes to the regulation of genes involved in neuronal differentiation and development. The protein plays a significant role in neural stem cell proliferation and the regulation of progenitor cell fate.

Pathways

The BAF53A protein participates actively in the neural development and chromatin remodeling pathways. It interacts closely with the BAF complex to regulate the transcription of genes essential for neural differentiation and development. The BAF complex which includes BAF53A associates with proteins such as BRG1 and SMARCC1 facilitating the unfolding of chromatin to affect gene expression positively.

Associated diseases and disorders

BAF53A is associated with neurodevelopmental disorders and certain types of cancer. Altered expression or mutations in BAF53A have been linked to neurodevelopmental issues contributing to conditions such as Autism Spectrum Disorders. Additionally overexpression of BAF53A connects to cancer particularly in glioblastoma where it influences tumor progression. In these contexts BAF53A interacts with oncogenes and tumor suppressor proteins playing a role in disease pathogenesis.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

2 product images

  • Western blot - Anti-BAF53A Antibody [RP23040194] (ab313478), expandable thumbnail

    Western blot - Anti-BAF53A Antibody [RP23040194] (ab313478)

    All lanes: Western blot - Anti-BAF53A Antibody [RP23040194] (ab313478) at 1 µg/mL

    Lane 1: MCF7 cell lysate at 30 µg

    Lane 2: K562 cell lysate at 30 µg

    Lane 3: HeLa cell lysate at 30 µg

    Lane 4: Jurkat cell lysate at 30 µg

    Lane 5: Ramos cell lysate at 30 µg

    Lane 6: HT29 cell lysate at 30 µg

    Secondary

    All lanes: Goat anti-Rabbit IgG (H+L) Secondary Antibody, HRP conjugate at 1/2500 dilution

    Developed using the ECL technique.

    Observed band size: 47 kDa

  • Immunocytochemistry/ Immunofluorescence - Anti-BAF53A Antibody [RP23040194] (ab313478), expandable thumbnail

    Immunocytochemistry/ Immunofluorescence - Anti-BAF53A Antibody [RP23040194] (ab313478)

    Immunofluorscent analysis of MCF-7 cells fixed with 4% formaldehyde reconstituted in 1X PBS for 10 min at room temperature and permabilized using 0.1 % Triton X-100 in PBS for 15 min at room temperature labeling endogenous Actl6a with ab313478 at 2 ?g/mL dilution followed by Goat anti-Rabbit IgG (H+L) Secondary Antibody, Alexa Fluor488 conjugate at 1/2000 dilution. Panel a) shows representative cells that were stained for detection and localization of Actl6a protein (green), Panel b) is stained for nuclei (blue) using DAPI. Panel c) represents cytoskeletal F-actin staining using Alexa Fluor555 Rhodamine Phalloidin at 1//300 dilution. Panel d) is a composite image of Panels a, b and c clearly demonstrating nuclear localization of Actl6a. Panel e) represents control cells with no primary antibody to assess background. The images were captured at 60X magnification.

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com